The U.S. post-acute care (PAC) market size was USD 459.97 billion in 2023, calculated at USD 482.97 billion in 2024 and is projected to surpass around USD 786.71 billion by 2034, expanding at a CAGR of 5% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: US Post-Acute Care (PAC) Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: US Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. US Post-Acute Care (PAC) Market, by Conditions, 2024-2034
8.1.1 Neurological Disorder
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Amputations
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Wound Management
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Brain Injury
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Spinal Cord Injury
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2021-2034)
9.1. US Post-Acute Care (PAC) Market, by Application, 2024-2034
9.1.1. Elderly
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Adult
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Child
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. US Post-Acute Care (PAC) Market, by Spending, 2024-2034
10.1.1. Skilled Nursing Facilities
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Home Care
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Long-Term Acute Care
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Inpatient Rehabilitation
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. U.S.
11.1.1. Market Revenue and Forecast, by Conditions (2021-2034)
11.1.2. Market Revenue and Forecast, by Application (2021-2034)
11.1.3. Market Revenue and Forecast, by Spending (2021-2034)
12.1. Brookdale Senior Living
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Athena Health Care Systems
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Genesis Healthcare
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. The Ensign Group Inc
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. LHS Group
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client